Surface plasmon resonance biosensors as a tool in antibody engineering

Biosensors and Bioelectronics

Volumn 13, Issue 6, 1998, Pages 653-663

  Alfthan, Kaija ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Antibody engineering; BIAcore; Biosensor; Phage display; Real time interaction analysis; Surface plasmon resonance

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; GENETIC ENGINEERING;

PHAGE DISPLAY; SURFACE PLASMON RESONANCE;

BIOSENSORS;

ANTIBODY;

ANTIGEN BINDING; BIOENGINEERING; BIOSENSOR; CONFERENCE PAPER; DEVICE; GENE TECHNOLOGY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR SIZE;

ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; HUMANS; PROTEIN ENGINEERING; SURFACE PLASMON RESONANCE;

EID: 0032531147     PISSN: 09565663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0956-5663(98)00020-7     Document Type: Conference Paper

References (93)

1. Abraham R., Buxbaum S., Link J., Smith R., Venti C., Darsley M. Screening and kinetic analysis of recombinant anti-CEA antibody fragments. J. Immunol. Methods. 183:1995;119-125.
2. Alfthan K., Takkinen K., Sizmann D., Seppälä I., Immonen T., Vanne L., Keränen S., Kaartinen M., Knowles J.K.C., Teeri T.T. Efficient secretion of murine Fab fragments by Escherichia coli is determined by the first constant domain of the heavy chain. Gene. 128:1993;203-209.
3. Alfthan K., Takkinen K., Sizmann D., Söderlund H., Teeri T.T. Properties of a single-chain antibody containing different linker peptides. Protein Eng. 8:1995;725-731.
4. Atwell J.L., Pearce L.A., Lah M., Gruen L.C., Kortt A.A., Hudson P.J. Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase. Mol. Immunol. 33:1996;1301-1312.
5. Batra J.K., Kasprzyk P.G., Bird R.E., Pastan I., King C.R. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin. Proc. Natl Acad. Sci. USA. 89:1992;5867-5871.
6. Better M., Chang C.P., Robinson R.R., Horwitz A.H. Escherichia coli secretion of an active chimeric antibody fragment. Science. 240:1988;1041-1043.
7. Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.-M., Lee T., Pope S.H., Riordan G.S., Whitlow M. Single-chain antigen-binding proteins. Science. 242:1988;423-426.
8. Borrebaeck C.A.K., Malmborg A.-C., Furebring C., Michaelsson A., Ward S., Danielsson L., Ohlin M. Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding. Bio/Technology. 10:1992;697-698.
9. Burton D.R., Barbas C.F., Persson M.A.A., Koenig S., Chanock R.M., Lerner R.A. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropostive individuals. Proc. Natl Acad. Sci. USA. 88:1991;10134-10137.
10. Caplen N.J., Alton E.W.F.W., Middleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffery P.K., Hodson M.E., Coutelle C., Huang L., Porteous D.J., Williamson R., Geddes D.M. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1:1995;39-46.
11. Carter P., Kelley R.F., Rodrigues M.L., Snedecor B., Covarrubias M., Velligan M.D., Wong W.L.T., Rowland A.M., Kotts C.E., Carver M.E., Yang M., Bourell J.H., Shepard H.M., Henner D. High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Bio/Technology. 10:1992;163-167.
12. Carter P., Merchant A.M. Engineering antibodies for imaging and therapy. Curr. Opin. Biotechnol. 8:1997;449-454.
13. Chaudhary V.K., Queen C., Junghans R.P., Waldmann T.A., FitzGerald D.J., Pastan I. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature. 339:1989;394-397.
14. Chester K.A., Hawkins R.E. Clinical issues in antibody design. TIBTECH. 13:1995;294-300.
15. Christensen L.L.H. Theoretical analysis of protein concentration determination using biosensor technology under conditions of partial mass transport limitation. Anal. Biochem. 249:1997;153-164.
16. Desplancq D., King D.J., Lawson A.D.G., Mountain A. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. Protein Eng. 7:1994;1027-1033.
17. Devlin C.M., Bowles M.R., Gordon R.B., Pond S.M. Production of a paraquat-specific murine single chain Fv fragment. J. Biochem. 118:1995;480-487.
18. Duenas M., Malmborg A.-C., Casalvilla R., Ohlin M., Borrebaeck C.A.K. Selection of phage displayed antibodies based on kinetic constants. Mol. Immunol. 33:1996;279-285.
19. Friquet B., Chaffotte A.F., Djavadi-Ohaniance L., Goldberg M.E. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods. 77:1985;305-319.
20. Glaser R.W. Antigen-antibody binding and mass transport by convection and diffusion to a surface: a two-dimensional computer model of binding and dissociation kinetics. Anal. Biochem. 213:1993;152-161.
21. Glockshuber R., Malia M., Pfitzinger I., Plückthun A. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry. 29:1990;1362-1367.
22. Gregoriadis G. Engineering liposomes for drug delivery: progress and problems. TIBTECH. 13:1995;527-537.
23. Griffiths A.D., Malmqvist M., Marks J.D., Bye J.M., Embleton M.J., McCafferty J., Baier M., Holliger K.P., Gorick B.D., Hughes-Jones N.C., Hoogenboom H.R., Winter G. Human anti-self antibodies with high specificity from phage display libraries. EMBO J. 12:1993;725-734.
24. Griffiths A.D., Williams S.C., Hartley O., Tomlinson I.M., Waterhouse P., Crosby W.L., Kontermann R.E., Jones P.T., Low N.M., Allison T.J., Prospero T.D., Hoogenboom H.R., Nissim A., Cox J.P.L., Harrison J.L., Zaccolo M., Gherardi E., Winter G. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:1994;3245-3260.
25. Hawkins R.E., Russell S.J., Winter G. Selection of phage antibodies by binding affinity: mimiking affinity maturation. J. Mol. Biol. 226:1992;889-896.
26. Hemminki A., Niemi S., Hautoniemi L., Söderlund H., Takkinen K. Fine tuning of an anti-testosterone antibody binding site by stepwise optimization of the CDRS. Immunotechnol. 4:1998;59-69.
27. Hodits R.A., Nimpf J., Pfistermueller D.M., Hiesberger T., Schneider W.J., Vaughan T.J., Johnsson K.S., Haumer M., Kuechler E., Winter G., Blaas D. An antibody fragment from a phage display library competes for ligand binding to the low density lipoprotein receptor family and inhibits rhinovirus infection. J. Biol. Chem. 270:1995;24078-24085.
28. Holliger P., Winter G. Engineering bispecific antibodies. Curr. Opin. Biotechnol. 4:1993;446-449.
29. Holliger P., Prospero T., Winter G. "Diabodies": small bivalent and bispecific antibody fragments. Proc. Natl Acad. Sci. USA. 90:1993;6444-6448.
30. Holliger P., Brissinck J., Williams R.L., Thielemans K., Winter G. Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. Protein Eng. 9:1996;299-305.
31. Hoogenboom H.R., Marks J.D., Griffiths A.D., Winter G. Building antibodies from their genes. Immunol. Rev. 130:1992;41-68.
32. Hoogenboom H.R. Designing and optimizing library selection strategies for generating high-affinity antibodies. TIBTECH. 15:1997;62-70.
33. Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.-S., Novothy J., Margolies M.N., Ridge R.J., Bruccoleri R.E., Haber E., Crea R., Oppermann H. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl Acad. Sci. USA. 85:1988;5879-5883.
34. Hutchinson A.M. Evanescent wave biosensors. Mol. Biotechnol. 3:1995;47-54.
35. Ito W., Kurosawa Y. Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A. J. Biol. Chem. 268:1993;20668-20675.
36. Jönsson U., Fägerstam L., Ivarsson B., Johnsson B., Karlsson R., Lundh K., Löfås S., Persson B., Roos H., Rönnberg I., Sjölander S., Stenberg E., Ståhlberg R., Urbanicsky C., Östlin H., Malmqvist M. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. BioTechniques. 11:1991;620-627.
37. Karlsson R., Michaelsson A., Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods. 145:1991;229-240.
38. Karlsson R., Fägerstam L., Nilshans H., Persson B. Analysis of active antibody concentration: separation of affinity and concentration parameters. J. Immunol. Methods. 166:1993;75-84.
39. Karlsson R., Roos H., Fägerstam L., Persson B. Kinetic and concentration analysis using BIA technology. Methods Enzymol. 6:1994;99-110.
40. Karlsson R., Mo J.A., Holmdahl R. Binding of autoreactive mouse anti-type II collagen antibodies derived from the primary and secondary immune response investigated with the biosensor technique. J. Immunol. Methods. 188:1995;63-71.
41. Karlsson R., Fält A. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance. J. Immunol. Methods. 200:1997;121-133.
42. Kazemier B., de Haard H., Boender P., van Gemen B., Hoogenboom H. Determination of active single chain antibody concentrations in crude periplasmic fractions. J. Immunol. Methods. 194:1996;201-209.
43. Kipriyanov S.M., Little M., Kropshofer H., Breitling F., Gotter S., Dübel S. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. Protein Eng. 9:1996;203-211.
44. Kirpotin D., Park J.W., Hong K., Zalipsky S., Li W.-L., Carter P., Benz C.C., Papahadjopoulos D. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry. 36:1997;66-75.
45. Kortt A.A., Lah M., Oddie G.W., Gruen C.L., Burns J.E., Pearce L.A., Atwell J.L., McCoy A.J., Howlett G.J., Metzger D.W., Webster R.G., Hudson P.J. Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. Protein Eng. 10:1997;423-433.
46. Kretschmann E. The determination of the optical constants of metals by excitation of surface plasmons. Z. Physik. 241:1971;313-324.
47. Lasonder E., Schellekens G.A., Welling G.W. A fast and sensitive method for the evaluation of binding of phage clones selected from a surface displayed library. Nucleic Acids Res. 22:1994;545-546.
48. Laukkanen M.-L., Teeri T.T., Keinänen K. Lipid-tagged antibodies: bacterial expression and characterization of a lipoprotein-single-chain antibody fusion protein. Protein Eng. 6:1993;449-454.
49. Laukkanen M.-L., Alfthan K., Keinänen K. Functional immunoliposomes harboring a biosynthetically lipid-tagged single-chain antibody. Biochemistry. 33:1994;11664-11670.
50. Laukkanen M.-L., Orellana A., Keinänen K. Use of genetically engineered lipid-tagged antibody to generate functional europium chelate-loaded liposomes: application in fluoroimmunoassay. J. Immunol. Methods. 185:1995;95-102.
51. Liedberg B., Nylander C., Lundström I. Surface plasmon resonance for gas detection and biosensoring. Sens. Actuators. 4:1983;299-304.
52. Lindner P., Bauer K., Krebber A., Nieba L., Kremmer E., Krebber C., Honegger A., Klinger B., Mocikat R., Plückthun A. Specific detection of his-tagged proteins with recombinant anti-his tag scFv-phosphatase or scFv-phage fusions. BioTechniques. 22:1997;140-149.
53. Löfås S., Johnsson B. A novel hydrogel matrix on gold surfaces in surface plasmon resonance sensors for fast and efficient covalent immobilization of ligands. J. Chem. Soc. Chem. Commun. 21:1990;1526-1528.
54. MacKenzie C.R., Hirama T., Deng S.-J., Bundle D.R., Narang S.A., Young N.M. Analysis of surface plasmon resonance of the influence of valence on the ligand binding affinity and kinetics of an anti-carbohydrate antibody. J. Biol. Chem. 271:1996;1527-1533.
55. Malmborg A.-C., Duenas M., Ohlin M., Söderlind E., Borrebaeck C.A.K. Selection of binders from phage displayed antibody libraries using the BIAcore™ biosensor. J. Immunol. Methods. 198:1996;51-57.
56. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:1991;581-597.
57. Marks J.D., Griffiths A.D., Malmqvist M., Clackson T.P., Bye J.M., Winter G. By-passing immunization: building high affinity human antibodies by chain shuffling. Bio/Technology. 10:1992;779-783.
58. McCafferty J., Griffiths A.D., Winter G., Chiswell D.J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 348:1990;552-554.
59. 2 made by protein folding and bonded through C-terminal cysteinyl peptides. Protein Eng. 8:1994;301-314.
60. Myszka D.G. Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Curr. Opin. Biotechnol. 8:1997;50-57.
61. Neri D., Momo M., Prospero T., Winter G. High-affinity antigen binding by chelating recombinant antibodies (CRAbs). J. Mol. Biol. 246:1995;367-373.
62. Nieba L., Krebber A., Plückthun A. Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics. Anal. Biochem. 234:1996;155-165.
63. Nilsson B. Antibody engineering. Curr. Opin. Struct. Biol. 5:1995;450-456.
64. Nissim A., Hoogenboom H.R., Tomlinson I.M., Flynn G., Midgley C., Lane D., Winter G. Antibody fragments from a "single pot" phage display library as immunochemical reagents. EMBO J. 13:1994;692-698.
65. Oddie G.W., Gruen L.C., Odgers G.A., King L.G., Kortt A.A. Identification and minimization of nonideal binding effects in BIAcore analysis: ferritin/anti-ferritin Fab′ interaction as a model system. Anal. Biochem. 244:1997;301-311.
66. O'Shannessy D.J., Brigham-Burke M., Soneson K.K., Hensley P., Brooks I. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal. Biochem. 212:1993;457-468.
67. O'Shannessy D.J., Winzor D.J. Interpretation of deviations from pseudo-first-order kinetic behavior in the characterization of ligand binding by biosensor technology. Anal. Biochem. 236:1996;275-283.
68. Pack P., Plückthun A. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli. Biochemistry. 31:1992;1579-1584.
69. Pack P., Müller K., Zahn R., Plückthun A. Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J. Mol. Biol. 246:1995;28-34.
70. Plückthun A., Skerra A. Expression of functional antibody Fv and Fab fragments in Escherichia coli. Methods Enzymol. 178:1989;497-515.
71. Plückthun A. Antibody engineering: advances from the use of Escherichia coli expression systems. Bio/Technology. 9:1991;545-551.
72. Plückthun A. Mono- and bivalent antibody fragments produced in Escherichia coli: engineering, folding and antigen binding. Immunol. Rev. 130:1992;151-188.
73. Plückthun A., Pack P. New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnol. 3:1997;83-105.
74. Pope A., Pritchard K., Williams A., Roberts A., Hackett J.R., Mandecki W., Johnson K.S. In vitro selection of a high affinity antibody to oestradiol using a phage display human antibody library. Immunotechnol. 2:1996;209-217.
75. Rader C., Barbas C.F. Phage display of combinatorial antibody libraries. Curr. Opin. Biotechnol. 8:1997;503-508.
76. Reiter Y., Brinkmann U., Lee B., Pastan I. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments. Nat. Biotechnol. 14:1996;1239-1245.
77. Rheinnecker M., Hardt C., Ilag L.L., Kufer P., Gruber R., Hoess A., Lupas A., Rottenberger C., Plückthun A., Pack P. Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. J. Immunol. 157:1996;2989-2997.
78. Richalet-Secordel P.M., Rauffer-Bruyere N., Christenssen L.L.H., Ofenloch-Haehnle B., Seidel C., Van Regenmortel M.H.V. Concentration measurement of unpurified proteins using biosensor technology under conditions of partial mass transport limitation. Anal. Biochem. 249:1997;165-173.
79. Rongen H.A.H., Bult A., van Bennekom W.P. Liposomes and immunoassays. J. Immunol. Methods. 204:1997;105-133.
80. Schier R., Marks R. Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections. Hum. Antibod. Hybridomas. 7:1996;97-105.
81. Schier R., McCall A., Adams G.P., Marshall K.W., Merritt H., Yim M., Crawford R.S., Weiner L.M., Marks C., Marks J.D. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementary determining regions in the center of the antibody binding site. J. Mol. Biol. 263:1996;551-567.
82. Schier R., Bye J., Apell G., McCall A., Adams G.P., Malmqvist M., Weiner L.M., Marks J.D. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J. Mol. Biol. 255:1996;28-43.
83. Skerra A., Plückthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science. 240:1988;1038-1041.
84. Skerra A. Bacterial expression of immunoglobulin fragments. Curr. Opin. Immunol. 5:1993;256-262.
85. Songsivilai S., Lachmann P.J. Bispecific antibody: a tool for diagnosis and treatment of disease. Clin. Exp. Immunol. 79:1990;315-321.
86. Takkinen K., Laukkanen M.-L., Sizmann D., Alfthan K., Immonen T., Vanne L., Kaartinen M., Knowles J.K.C., Teeri T.T. An active single-chain antibody containing a cellulase linker domain is secreted by Escherichia coli. Protein Eng. 4:1991;837-841.
87. Thompson J., Pope T., Tung J.-S., Chan C., Hollis G., Mark G., Johson K.S. Affinity maturation of high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. J. Mol. Biol. 256:1996;77-88.
88. Vaughan T.J., Williams A.J., Pritchard K., Osbourn J.K., Pope A.R., Earnshaw J.C., McCafferty J., Hodits R.A., Wilton J., Johnson K.S. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat. Biotechnol. 14:1996;309-314.
89. Wels W., Hatwerth I.-M., Zwickl M., Hardman N., Groner B., Hynes N.E. Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphatase fusion protein targeted to the human erbB-2 receptor. Bio/Technology. 10:1992;1128-1132.
90. Whitlow M., Filpula D., Rollence M.L., Feng S.-L., Wood J.F. Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv. Protein Eng. 7:1994;1017-1026.
91. Winter G., Griffiths A.D., Hawkins R.E., Hoogenboom H.R. Making antibodies by phage display technology. Annu. Rev. Immunol. 12:1994;433-455.
92. Yang W.-P., Green K., Pinz-Sweeney S., Briones A.T., Burton D.R., Barbas C.F. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J. Mol. Biol. 254:1995;392-403.
93. Zhu Z., Zapata G., Shalaby R., Snedecor B., Chen H., Carter P. High level secretion of a humanized bispecific diabody from Escherichia coli. Bio/Technology. 14:1996;192-196.